5 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 5 best genomic stocks to buy now.
Intellia Therapeutics Inc. (NTLA)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 7,684,441 | $1,244,188 | -21% | 2.31% |
| 2. | Darwin Global Management Abhishek Trehan | 1,859,926 | $301,141 | 48.57% | |
| 3. | Viking Global Andreas Halvorsen | 975,092 | $157,877 | 0.47% | |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 462,978 | $74,961 | 0.14% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 410,217 | $66,418 | -40% | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.50 | 4,250 | Officer | 7,500 | 2019-03-06 | Filing | |
| $16.00 | 3,250 | Officer | 3,250 | 2019-03-06 | Filing | |
| $18.00 | 58,534 | Director | 2,662,180 | 2016-05-11 | Filing | |
| $18.00 | 191,466 | Director | 2,603,646 | 2016-05-11 | Filing | |
| $18.00 | 300,000 | Large Shareholder | 790,527 | 2016-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $130.47 | 250 | Officer | 8,714 | 2021-10-14 | Filing | |
| $129.83 | 525 | Officer | 8,964 | 2021-10-14 | Filing | |
| $129.01 | 225 | Officer | 9,489 | 2021-10-14 | Filing | |
| $127.81 | 849 | Officer | 9,714 | 2021-10-14 | Filing | |
| $126.92 | 551 | Officer | 10,563 | 2021-10-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,900 | $255,000 | 0% | |
| 2. | 1,410 | $189,152 | 0.01% | |
| 3. | 1,158,732 | $155,445 | 0.54% | |
| 4. | 111,440 | $14,950 | 1.76% | |
| 5. | 26,491 | $3,554 | 0.02% |
News See All
Hedge Funds Are Crazy About Intellia Therapeutics, Inc. (NTLA)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Is Intellia Therapeutics (NTLA) A Great Investment Pick?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
12 Best ARK Stocks To Invest In
As technology and growth stocks surged during the pandemic, ARK Investment Management and Cathie Wood became two of retail investors' favorites over the previous year.
Hedge Funds Are Cashing Out Of Intellia Therapeutics, Inc. (NTLA)
Is Intellia Therapeutics, Inc.
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
5 Best Biotech Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best biotech stocks to buy according to Cathie Wood.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
5 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we discuss the 5 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is NTLA Stock A Buy or Sell?
In this article you are going to find out whether hedge funds think Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a good investment right now.
Billionaire Hedge Funds
